Back to 
GEODE CAPITAL MANAGEMENT, LLC
GEODE CAPITAL MANAGEMENT, LLC
SMMT
Showing 0 of 2 quarters
Position history for GEODE CAPITAL MANAGEMENT, LLC's holdings in SUMMIT THERAPEUTICS-SPON ADR
No. Geode Capital Management exited its SMMT (Summit Therapeutics) position in Q3 2020. Its Q2 2020 13F listed 19,411 shares worth $57,000. Geode Capital Management first reported SMMT in Q2 2020 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.